These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 2157322

  • 1. Hepatocellular carcinoma versus carcinoma metastatic to the liver. Value of stains for carcinoembryonic antigen and naphthylamidase in fine needle aspiration biopsy material.
    Wong MA, Yazdi HM.
    Acta Cytol; 1990; 34(2):192-6. PubMed ID: 2157322
    [Abstract] [Full Text] [Related]

  • 2. Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections.
    Balaton AJ, Nehama-Sibony M, Gotheil C, Callard P, Baviera EE.
    J Pathol; 1988 Dec; 156(4):305-10. PubMed ID: 2465399
    [Abstract] [Full Text] [Related]

  • 3. Polyclonal carcinoembryonic antigen staining in the cytologic differential diagnosis of primary and metastatic hepatic malignancies.
    Wolber RA, Greene CA, Dupuis BA.
    Acta Cytol; 1991 Dec; 35(2):215-20. PubMed ID: 1709323
    [Abstract] [Full Text] [Related]

  • 4. Role of CD10 immunochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver.
    Ahuja A, Gupta N, Kalra N, Srinivasan R, Chawla Y, Rajwanshi A.
    Cytopathology; 2008 Aug; 19(4):229-35. PubMed ID: 18070122
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver.
    Lin F, Abdallah H, Meschter S.
    Diagn Cytopathol; 2004 Feb; 30(2):92-7. PubMed ID: 14755758
    [Abstract] [Full Text] [Related]

  • 6. Immunocytochemical localization of polyclonal carcinoembryonic antigen in hepatocellular carcinomas.
    Carrozza MJ, Calafati SA, Edmonds PR.
    Acta Cytol; 1991 Feb; 35(2):221-4. PubMed ID: 1851357
    [Abstract] [Full Text] [Related]

  • 7. MOC-31 aids in the differentiation of metastatic adenocarcinoma from hepatocellular carcinoma.
    Niemann TH, Hughes JH, De Young BR.
    Cancer; 1999 Oct 25; 87(5):295-8. PubMed ID: 10536355
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytology.
    Saad RS, Luckasevic TM, Noga CM, Johnson DR, Silverman JF, Liu YL.
    Diagn Cytopathol; 2004 Jan 25; 30(1):1-6. PubMed ID: 14696137
    [Abstract] [Full Text] [Related]

  • 9. Discriminating hepatocellular carcinoma from metastatic carcinoma on fine-needle aspiration biopsy of the liver: the utility of immunocytochemical panel.
    Saleh HA, Aulicino M, Zaidi SY, Khan AZ, Masood S.
    Diagn Cytopathol; 2009 Mar 25; 37(3):184-90. PubMed ID: 19170172
    [Abstract] [Full Text] [Related]

  • 10. Immunocytochemical staining of fine-needle aspiration biopsies of the liver as a diagnostic tool for hepatocellular carcinoma.
    Johnson DE, Powers CN, Rupp G, Frable WJ.
    Mod Pathol; 1992 Mar 25; 5(2):117-23. PubMed ID: 1374187
    [Abstract] [Full Text] [Related]

  • 11. Immunoperoxidase staining as a diagnostic aid for hepatocellular carcinoma.
    Christensen WN, Boitnott JK, Kuhajda FP.
    Mod Pathol; 1989 Jan 25; 2(1):8-12. PubMed ID: 2466290
    [Abstract] [Full Text] [Related]

  • 12. Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma.
    Röcken C, Licht J, Roessner A, Carl-McGrath S.
    J Clin Pathol; 2005 Oct 25; 58(10):1069-75. PubMed ID: 16189153
    [Abstract] [Full Text] [Related]

  • 13. The clinical utility of the Das-1 monoclonal antibody in identifying adenocarcinoma of the colon metastatic to the liver in fine-needle aspiration tissue.
    Zimmerman RL, Das KM, Burke MA, Young NA, Solomides CC, Bibbo M.
    Cancer; 2002 Dec 25; 96(6):370-3. PubMed ID: 12478685
    [Abstract] [Full Text] [Related]

  • 14. Glypican-3 immunocytochemistry in liver fine-needle aspirates : a novel stain to assist in the differentiation of benign and malignant liver lesions.
    Kandil D, Leiman G, Allegretta M, Trotman W, Pantanowitz L, Goulart R, Evans M.
    Cancer; 2007 Oct 25; 111(5):316-22. PubMed ID: 17763368
    [Abstract] [Full Text] [Related]

  • 15. Can CD34 discriminate between benign and malignant hepatocytic lesions in fine-needle aspirates and thin core biopsies?
    de Boer WB, Segal A, Frost FA, Sterrett GF.
    Cancer; 2000 Oct 25; 90(5):273-8. PubMed ID: 11038423
    [Abstract] [Full Text] [Related]

  • 16. Immunocytochemical evaluation of liver fine-needle aspirations.
    Bedrossian CW, Davila RM, Merenda G.
    Arch Pathol Lab Med; 1989 Nov 25; 113(11):1225-30. PubMed ID: 2479356
    [Abstract] [Full Text] [Related]

  • 17. Two-color immunostaining of liver fine needle aspiration biopsies with CD34 and carcinoembryonic antigen. Potential utilization in the diagnosis of primary hepatocellular carcinoma vs. metastatic tumor.
    Yoder M, Zimmerman RL, Bibbo M.
    Anal Quant Cytol Histol; 2004 Apr 25; 26(2):61-4. PubMed ID: 15131892
    [Abstract] [Full Text] [Related]

  • 18. Utility of polyclonal and monoclonal antibodies against carcinoembryonic antigen in hepatic fine-needle aspirates.
    Rishi M, Kovatich A, Ehya H.
    Diagn Cytopathol; 1994 Dec 25; 11(4):358-61; discussion 361-2. PubMed ID: 7895575
    [Abstract] [Full Text] [Related]

  • 19. Immunohistochemical study on hepatic tumors--KM01 stains compared with AFP, CEA, CA19-9 and RAS P21.
    Hanabata M, Ohyanagi H, Saitoh Y, Itoh H.
    Kobe J Med Sci; 1991 Apr 25; 37(2):81-96. PubMed ID: 1717740
    [Abstract] [Full Text] [Related]

  • 20. Fine needle aspiration biopsy of hepatocellular carcinoma. Value of immunocytochemical and ultrastructural studies.
    Guindi M, Yazdi HM, Gilliatt MA.
    Acta Cytol; 1994 Apr 25; 38(3):385-91. PubMed ID: 7514832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.